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Abstract
Staphylococcus aureus is one of the most important pathogens, causing various diseases in
humans and animals. In addition, S. aureus is a common foodborne pathogen. As methicillinresistant S. aureus (MRSA) becomes increasingly prevalent, controlling this pathogen in animals
and humans with standard antibiotic treatment has become challenging. Combinations of
different antimicrobial agents represent one of the most promising approaches for combating
multidrug – resistant bacteria both for treatment of clinical disease as well as in food. Two such
antimicrobials with potential application in the food industry include essential oils (EO) and
host-specific bacteriophage (phage). The objectives of this study were 1) to determine the
efficacy of varying concentrations of pure EOs compounds against S. aureus and 2) to evaluate
the efficacy of a S. aureus-specific bacteriophage against 4 strains of S. aureus. The overall goal
was to combine these antimicrobials to determine potential synergism and possible application
for the control of S. aureus on raw chicken products. Four EO compounds were evaluated by
disc diffusion assay to determine inhibitory effects against five strains of S. aureus. Next, a
growth inhibition assay was performed using a 96-well plate bioassay to measure change in
optical density over a 48-hour period. Phage adsorption assays were performed up to 120 h at 6,
13, and 37°C to determine lytic activity. The results from disc diffusion, growth inhibition, and
phage adsorption assays indicate that EO compounds and bacteriophage can be used as
antimicrobials against S. aureus. For application in the food industry, these antimicrobials were
evaluated for their efficacy against S. aureus on raw chicken pieces at 6, 13, and 25°C. Results
indicate that at 25°C phage K alone inhibits S. aureus growth better as compared to other
antimicrobial combination. At 6 and 13°C, there was no significant effect of EO and phage alone
or in combination against S. aureus when applied on the raw chicken pieces. Therefore, for these

antimicrobials to work in vivo such as raw meat products, a better delivery method should be
employed for a uniform application on meat.
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Chapter 1: Literature Review
Staphylococcus aureus
Introduction
Staphylococcus aureus is an aerobic Gram-positive bacterium that occurs in grape like clusters.
They are non-motile, non-spore forming, spherical cells of 1 µm in diameter. It is a member of
the Micrococcaceae family (Franklin, 1998). The organism was first discovered in 1880 by a
surgeon named Sir Alexander Ogsten. In 1884, Rosenbach proposed two pigmented types of the
cocci. The bacterium that produced yellow colonies was known as S. aureus and the one that
produced non-pigmented or white colonies was known as S. epidermidis. It is an opportunistic
pathogen found in humans and animals and is one of the most common sources of hospital and
community-acquired infections (Alsaimary, 2012). The organism is a commensal colonizer of
the skin and is common inhabitant of the nasal passage (25-30% of people), mucous membranes
(e.g., throat, axilla, and rectum) and other anatomical locales on humans and other warm-blooded
mammals (Chao et al., 2008).
Biochemical Characteristics
According to a review by Panneerseelan and Muriana (2009), Staphylococcus aureus are
facultative anaerobes and they can grow by aerobic respiration or by fermentation producing
lactic acid. The organism can grow at a wide temperature range (15°C to 45°C), a pH range of 4
to 11 and at NaCl concentrations as high as 15%. These characteristics enable S. aureus to grow
in a wide variety of environments including foods. The bacteria are catalase-positive and
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oxidase-negative. It is hemolytic on blood agar and almost all strains of S. aureus produce the
enzyme coagulase. The organism ferments glucose and mannitol producing lactic acid.
Antibiotic Resistance
The widespread use of antibiotics has provoked an exponential increase in the incidence of
antibiotic resistance in several bacterial groups in recent years. Staphylococcus aureus are
notorious for their resistance to antibiotics. The occurrence of methicillin resistant S. aureus
(MRSA) and the detection of a vancomycin resistance gene in S. aureus during the late 1950s
and the early 1960s, has led to increased concern regarding this microorganism (Panneerseelan
and Muriana, 2009).
Methicillin Resistance
Methicillin-resistant S. aureus is a special type of S. aureus that is resistant to the antibacterial
activity of methicillin and other related antibiotics of the penicillin class (Alsaimary, 2012).
Staphylococcus aureus infections are traditionally treated with penicillins. The organism
developed resistance to penicillins via the BlaZ penicillinase (β-lactamase). In this mechanism,
β-lactamase produced by the bacteria provide antibiotic resistance by breaking the β-lactam ring
during hydrolysis, thus deactivating the antibiotic’s antibacterial properties (Alsaimary, 2012). In
1959, Beecham developed a penicillinase-stable penicillin called methicillin to overcome this
resistance mechanism (Wendlandt et al., 2013). The first isolates of MRSA were documented in
the late 1950s. By 1967, multidrug resistant MRSA were reported from Switzerland, India,
France, Denmark, England and Australia (Grundmann et al., 2006). Virulence and quorumsensing mechanisms allow S. aureus to cause a broad variety of serious infections in humans
(Miller et al., 2001). The genetic diversity and ability to acquire exogenous genes allows MRSA
2

to modulate its pathogenicity by adapting to changing environmental conditions and thus
acquiring resistance to multiple antibiotics (Wendlandt et al., 2013). The U.S. Centers for
Disease Control and Prevention (CDC) have reported that the proportion of overall
staphylococcal infections due to MRSA has risen from 2% in 1974 to 22% in 1995, and then to
65% in 2004 in the U.S. (Chao et al., 2008). Methicillin-resistant S. aureus are one of the most
common nosocomial pathogens throughout the world causing a wide range of hospital-linked
infections (Lee, 2003). Now concerns have intensified as MRSA has resulted in human
infections linked to unexpected community settings: children in day-care centers, army recruits,
athletes in contact sports, prison populations, and intra-venous drug users (Klevens et al., 2007).
Methicillin-resistant S. aureus also been detected in food animals and in food such as meat, milk
and dairy products and fishery products (Lee, 2003).
Vancomycin Resistance
Vancomycin has been a reliable treatment for gram positive bacterial infection for more than 30
years. Injectable forms of vancomycin were introduced in 1991 and since then have been used
for MRSA infection. The first report on a strain of S. aureus with reduced susceptibility to
vancomycin was reported in 1996 (Hiramatsu et al., 1997). It was called Mu 50 (vancomycin
minimum inhibitory concentration [MIC] 8 mg/L). The bacterial strain had an intermediate
resistance to vancomycin and was known as vancomycin-intermediate S. aureus (VISA). By
2002, eight documented cases of infection with VISA were reported (Smith et al., 1999). A CDC
report in 2002 reported on the first documented case of S. aureus infection caused by
vancomycin resistant S. aureus (VRSA) (Smith et al., 1999).
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Enterotoxins
Staphylococcus aureus produces enterotoxins that are the causative agents of foodborne
intoxications. Enterotoxins are single chain polypeptides with a molecular weight of 26-28 kDa
and contains 228-239 amino acid residues (Muller-Alouf et al., 2001). There are twenty
serological types of staphylococcal enterotoxins (SEs), the most common of which are SEA,
SEB, SEC, SED and SEE. They are classified into classical and novel enterotoxins. The
enterotoxin genes are present on regions of the chromosome known as staphylococcal
pathogenicity islands (SaPIs) (Balaban and Rasooly, 2000). The genes expressed in one
environment may not be expressed in another (Normanno et al., 2005). These enterotoxins are
active in minute quantities and are resistant to conditions such as heat treatment and low pH that
would normally kill the bacteria that produce them. They can remain potent in the digestive tract
as they are also resistant to proteolytic enzymes (Argudin et al., 2010). As a result, toxins present
before cooking may not be killed in most food preparation regimens (Panneerseelan and
Muriana, 2009).
Staphylococcal enterotoxins belong to a large family of staphylococcal and streptococcal
pyrogenic exotoxins, sharing common phylogenetic relationships, structure, function, and
sequence homology. These toxins cause toxic shock-like syndromes and have been implicated in
several allergic and autoimmune diseases along with food poisoning (Balaban and Rasooly,
2000). Duration of the illness usually lasts 6-24 h and prolonged illness or death can occur in
infants, elderly, and severely immune compromised persons (Panneerseelan and Muriana, 2009).
Staphylococcus aureus enterotoxins are also powerful super antigens (SAgs) that are able to
stimulate polyclonal proliferation response of human T-lymphocytes (O’Hehir and Lamb, 1990).
The T-cell proliferation results in a massive release of chemokines and pro-inflammatory
4

cytokines by bypassing conventional antigen recognition by T-cell receptors; thus, this T-cell
mediated response can affect the immune system of infected individuals, leading to potential
toxic shock syndrome and emesis in the case of food poisoning (Argudin et al., 2010). This helps
in the early detection of the infection in the body as the body shows the symptoms of
intoxication at an early stage (Panneerseelan and Muriana, 2009).
Transmission of Staphylococcus aureus in food
Food poisoning is a common form of illness, and it can vary in severity from being mild to fatal
(Loir et al., 2003). Food poisoning caused by infectious agents (bacteria, viruses, parasites) can
be broadly classified into two categories, namely foodborne infections and foodborne
intoxications. Foodborne infections occur when food consumed is contaminated with pathogens.
The pathogen causes inflammation, resulting in poor absorption of water and nutrients. Food
intoxications on the other hand may result from ingesting food contaminated with preformed
toxins produced by foodborne pathogens (Bergdoll et al., 1989). Hence even if the
microorganisms are destroyed during cooking or processing, some of the toxins which are heat
stable may persist in foods and may still cause intoxication (Panneerseelan and Muriana, 2009).
Staphylococcus aureus is a commensal and lives on the anatomical locales of humans and
animals. Hence food handlers are the common source of contamination of foods (Gutierrez et al.,
2012). Foods such as salads including egg, chicken or potato salads and sandwiches which are
hand-made and require no additional cooking are common sources of S. aureus. Other sources of
food contamination include the equipment and surfaces on which food is prepared. The bacteria
can multiply quickly at room temperature to produce SEs. The organism also enters the food
during processing of animal products. Staphylococcal enterotoxins in suspect foods must be
5

identified quickly because they are potent even in very minute quantities. In dairy products a
concentration of SEs as low as 0.5 ng/ml have resulted in 850 cases of foodborne illness in
children (Panneerseelan and Muriana, 2009).
Staphylococcal food poisoning results from the consumption of food contaminated with one or
more staphylococcal enterotoxins (SEs). The toxins of S. aureus are known as enterotoxins
because they are able to promote water loss from the small intestine mucosa resulting in
vomiting and diarrhea (Martin et al., 2003). It can also cause acute enteric responses such as
nausea, abdominal cramps, and changes in blood pressure. Staphylococcal food poisoning is
characterized by a short onset time (2 to 6 h) after ingestion of preformed toxins (Panneerseelan
and Muriana, 2009). Staphylococcal enterotoxin A is the most common enterotoxin implicated in
food-poisoning outbreaks in the US (77.8% of all outbreaks) followed by SED (37.5%) and SEB
(10%) (Balaban and Rasooly, 2000). However, it is not clear if an outbreak is caused as a result
of an individual toxin or if it is caused due to a combination of multiple toxins. Considerable
research has been conducted in detection of enterotoxins in foods. Development of
immunoassays has revolutionized the process; however, the need for improving the limit of
detection is important as SEs are potent in minute quantities (Balaban and Rasooly, 2000).
Staphylococcus aureus is also known to form biofilms on food surfaces (Gutierrez et al., 2012).
Biofilms are the most common bacterial lifestyle in nature. A biofilm is any group of
microorganisms in which cells stick to each other on a surface (food products). After initial
attachment of cells to a surface, they start to multiply and secrete a consistent matrix of
extracellular polymeric substances in which cells are wrapped (Gutierrez et al., 2012). S. aureus
is one of the major causative agents of food-borne diseases in humans. O’Brien et al. (2012)
showed that S. aureus were prevalent in 64.8% pork samples (256 out of 395) collected across
6

the U.S. (36 stores) and both susceptible and methicillin-resistant S. aureus were detected.
Overall, outbreaks caused by S. aureus in meat and poultry dishes caused 55% of the reported S.
aureus outbreaks from 1998-2008 with pork and pork dishes such as ham being the most
common (Bennett et al., 2013).
Poor hygiene practices in food processing plants can result in the contamination of food products
with pathogens potentially causing serious health issues for consumers. Since bacteria can attach
to food contact surfaces and form biofilms, the complete elimination of pathogens from the food
processing environment has been a difficult task as biofilms protect bacteria from the effects of
antimicrobial agents (Savage et al., 2013). Moreover, pathogens can survive even after cleaning
and disinfection. S. aureus can survive in hostile environments such as food industry surfaces
through their ability to form biofilms on food surfaces (Gutierrez et al., 2012).
Essential oil Compounds as Antimicrobials
Introduction
An essential oil (EO) is a concentrated hydrophobic liquid containing volatile aroma compounds
from plants. It has an oily consistency (Palmer et al., 1998). Essential oils are also known as
volatile oils, ethereal oils or aetherolea. Most of them are liquid at room temperature though a
few of them can be solid or resinous (Bassole et al., 2012). Their colors range from pale yellow
to emerald green and from blue to dark brownish red (Balz, 1999). Most of the plant organs such
as buds, flowers, leaves, barks, fruits, seeds, etc. synthesize essential oils and store them in
secretory cells, cavities, canals and epidermic cells (Upadhyay et al., 2010).
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Essentials oils do not form a distinctive category for any medical, pharmacological or culinary
purpose. They are generally extracted by distillation, often by using steam. They are used in
perfumes, cosmetics, soaps and other products, for flavoring food and drink and for adding
scents to incense and household cleaning products (Ciocan et al., 2007).
Mode of Action
Most of the antimicrobial activity in EOs appears to derive from terpenoids particularly phenolic
terpenes, phenylpropanoids and alcohols. Other constituents such as hydrocarbons show low
activities but can be used in combinations to increase their bioactivities (Bassole et al., 2012).
Interactions between these compounds may lead to antagonistic, additive or synergistic effects.
The most common mechanism of antimicrobial interaction is by synergism (Ciocan et al., 2007).
This includes the sequential inhibition of a common biochemical pathway, inhibition of
protective enzymes, and the use of cell wall active agents to enhance the uptake of other
antimicrobials. This mechanism involving a combination of components having synergistic
effect will then reduce the concentration needed to yield the same microbial effect when
compared with the sum of the purified components. There are many studies that have
demonstrated that crude EOs have higher antimicrobial activity than the mixtures of their major
components. When a combination of EOs is used, their synergistic activity can play a critical
role in the overall antimicrobial activity (Palmer et al., 1997).
Application in food products
It is widely believed that EOs and other plant products have healing powers. There is evidence
that Neanderthals living 60,000 years ago used a plant called hollyhock for medicinal purposes,
and today, it is still used in ethno medicine around the world (Burt, 2004). Today around one8

half of all pharmaceuticals dispensed in the U.S. have plant origins; however, very few of them
are used as antimicrobials (Ciocan et al., 2007). As drug resistance in microbes is becoming
increasingly prevalent, plant origin herbal medicines are considered as alternatives to synthetic
drugs and possess antimicrobial, anticancer, and antioxidant properties. There are some forms of
traditional medicines such as Ayurveda, Homeopathy, and Unani, which utilize plant products
for drug production (Upadhyay et al., 2010). Plant derived medicines have made large
contributions to human health and well-being (Upadhyay et al., 2010). Plant derived products act
either as natural blueprints for the development of new drugs or a phytomedicinals to be used for
the treatment of disease. The primary benefits of using such products are that they are
comparatively safer than the synthetic alternatives, thus offering therapeutic benefits and
affordable treatment (Edwards-Jones et al., 2004).
Food products may become easily contaminated with microbes such as bacteria, yeasts and
fungi. These microorganisms cause undesirable effects such as deterioration of the flavor, odor,
color, sensory, and textual properties of foods. In packaged foods, pathogenic microorganisms
including Listeria monocytogenes, S. aureus, Campylobacter, Salmonella, Escherichia coli, and
Clostridium perfringens, may continue to grow and survive, despite changes that may occur in
intrinsic factors such as pH, water activity, and lower oxygen level or extrinsic factors such as
temperature, time and humidity (Nazzaro et al., 2013). As a result, food products such as
cheeses, meats, poultry, and baked products are susceptible to microbial spoilage even after
packaging (Kuorwel et al., 2011). To prevent the growth of spoilage and pathogenic
microorganisms on foods, new preservation techniques have been developed as consumers
demand safe, fresh, and minimally processed foods. “Active packaging” (AP) technologies are
the latest technique to provide safe food products with longer shelf lives (Kuorwel et al., 2011).
9

The AP technologies are primarily based on the use of synthetic or natural antimicrobial (AM)
agents such as EOs. In food industries, food spoilage caused by microorganisms is reduced by
the use of different AM agents that are incorporated directly into the food. According to Kuorwel
et al. (2011), this method has some disadvantages including (i) consumers may prefer food
products with no or minimal synthetic agents because of concerns about potential side-effects;
(ii) incorporation of such AM agents in the bulk of the food may not be justified as food spoilage
occurs primarily on the surface; (iii) these agents might possess a distinct flavor which may
render the food flavor; and (iv) if AM agents are used in the food product, they have to be
declared on the package which may deter some consumers from purchasing the product. In spite
of these disadvantages, AM agents are still used as an additional protective barrier in food
industries (Kuorwel et al., 2011). Also, in order to obtain antimicrobial activity against
microorganisms on food products, the concentration of EOs is generally higher than the
concentration applied for flavoring purposes. This may result in food tainting or adverse
sensorial effects to certain food products (Bassole et al., 2012). In order to reduce adverse
sensory issues in food products that may be caused due to the presence of EO, lower
concentrations of EO must be used that can yield a similar antimicrobial activity (Bassole et al.,
2012).
Potential as Anti-Staphylococcal Compounds
Due to the widespread use of antibiotics during 1960s in order to minimize the spread of S.
aureus spread, resistant forms of S. aureus (MRSA and VRSA) were isolated soon. The public
health impact of both widespread VRSA and MRSA can be quite significant. In short it became
essential to find alternative, natural antimicrobials to treat staphylococcal infections (Li et al.,
2011). Plant sources of antimicrobial compounds are good candidates for limiting MRSA
10

without doing any harm to humans since some oils have been used in the past for curative
purposes (Li et al., 2011).
Methicillin resistant S. aureus is susceptible to tea tree oil but there are concerns about its
toxicity (Chao et al., 2008). Tea tree oil obtained from the Australian tree, Melaleuca
alternifolia, is a powerful antimicrobial agent against bacteria, fungi, and viruses and is used
commercially in a wide range of products (Edwards-Jones et al., 2004). According to Cox et al.
(2000), tea tree oil has the ability to disrupt the permeability barrier of cell membranes of
bacteria such as E. coli and S. aureus which results in the loss of chemiosmotic control in the
organisms. Upadhyay et al. (2010) reported that Ajwaine oil is highly lethal to S. aureus,
Streptococcus pneumonia, and Lactobacillus acidophilus. These authors also

showed that

bavchi oil and olive oil have antimicrobial activity against S. aureus. In addition, Chao et al.,
(2008) reported inhibitory zones of 45 to 83 mm against S.aureus with EOs such as lemongrass,
lemon myrtle, mountain savory, cinnamon bark and Melissa.
There are hundreds of other EOs available for use, many with known antimicrobial properties
(Chao et al., 2008). These oils contain numerous constituents that contribute to the /characteristic
odor and medical effects. The presence and quantity of the various chemical compound
components varies between oils and this determines the individuality of the oil. Due to the lack
of scientific evidence of their efficacy as conventional antimicrobial treatments combined with
their toxicity issues, medical teams rarely use EOs in spite of their proven antimicrobial
properties (Edwards-Jones et al., 2004).
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Bacteriophage therapy
Introduction
The widespread emergence of multiple antibiotic resistant pathogenic bacteria including strains
of E. coli, Staphylococcus sp., Streptococcus sp., Pseudomonas sp., etc., has become a
significant problem in treating bacterial infections of humans and animals. Scientists are now
predicting a return to the pre-antibiotic era in order to find alternatives to the use of antibiotics to
control bacterial pathogens (Rapson, 2002). A varied and large source of antibiotic agents
specifically active against a wide range of bacterial infections (including MRSA) is the lytic
bacteriophage population (Rapson, 2002). Bacteriophages are bacterial viruses that are able to
infect specific bacterial species. Similar to other viruses, they are obligate parasites that are able
to replicate only in living cells. A bacteriophage particle usually consists of a single nucleic acid
molecule which may be single-stranded or double-stranded, linear or circular DNA, or singlestranded linear RNA. The three major morphological classes of the bacteriophages are
icosahedral, icosahedral tailed, and filamentous (Platt, 2010). Bacteriophages have a specific
host range because they require specific receptors on the host cell surface to bind and initiate an
infection (Balasubramanian et al., 2007). They are nontoxic to humans, animals, and plants.
Bacteriophages were first discovered in 1915 from Staphylococcus sp. by a

British

bacteriologist, Frederick W Twort, and independently in 1917 from Shigella dysenteriae by a
Canadian medical bacteriologist, Felix Hubert d’Herelle (Summers, 2001). D’Herelle named the
invisible microbe that was an obligate parasite of living bacteria he found “a bacteriophage” or
by the shortened term “phage”. The therapeutic potential of bacteriophages was also realized
early on by d’Herelle who laid the foundation for experimental phage work, and by 1940,
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research involving bacteriophage therapy applications were being published in great numbers
indicating the utility of bacteriophage as a promising antibacterial agent.
Mode of Action
Bacteriophages have two distinct life cycles, lytic and lysogenic. In the lytic cycle,
bacteriophages utilize the host cells’ replication machinery and precursors to produce many
phage particles, and then end the cycle by lysing the host cells. In the lysogenic cycle, no
progeny particles are produced and the bacteriophage DNA usually becomes part of the bacterial
chromosome by site-specific recombination (Platt, 2010). Examples of lysogenic phage include λ
phage of E. coli and P22 of Salmonella Typhimurium (Platt, 2010). The decision on whether to
utilize lytic or lysogenic growth depends on several factors, including the expression of the
bacteriophage repressor and the nutritional status of the host (Platt, 2010). A phage capable only
of lytic growth is called a virulent phage while a bacteriophage capable of both lytic and
lysogenic growth is called a temperate phage. The bacterial host that contains a complete set of
bacteriophage DNA in the chromosome is called a lysogen. A bacteriophage whose genome is
inserted and integrated into a bacterial DNA chromosome is called a prophage (Summers, 2001).
Some prophages in a population of lysogens may switch to the lytic growth cycle and continue to
release small amount of progeny bacteriophages into the environment. The progeny
bacteriophages will then repeat the infection cycle in their susceptible host (Platt, 2010).
Limitations of Bacteriophage therapy
In spite of the successes in the bacteriophage therapy studies, it is not found routinely in the
toolkits of infectious disease specialists, public health workers, and hospital infection control
officers, because of its limitations (Summers, 2001). The causes of its limitations included the
13

narrow host range of a particular bacteriophage, and a specific bacteriophage is needed to treat a
specific bacterial infection. If an infection is caused by a mix of bacterial pathogens, one
bacteriophage could not stop the infection but rather a mixture of different bacteriophages
specific to each bacterial pathogen would be required (Summers, 2001). The emergence of
bacteriophage resistant bacteria is also possible through the selection of mutants (Platt, 2010).
Furthermore, lysogen of a temperate bacteriophage can become immune to a super infection with
the same bacteriophage and able to perpetuate the infection (Platt, 2010).
Staphylococcus aureus specific bacteriophage
Staphylococcus aureus bacteriophages encode proteins that target components of the DNA
replication and RNA transcription machinery of S. aureus (Kwan et al., 2005). Kwan et al.
(2005) have reported the complete genomic sequences and predicted proteins of 27
bacteriophages of S. aureus. In dairy industry, mastitis caused by S. aureus is a major concern,
and the most important source of milk contamination. The ability of the lytic S. aureus
bacteriophage K to eliminate bovine S. aureus intramammary infection during lactation has been
studied; however, Garcia et al. (2008) reported that the infused phage showed significant
degradation or inactivation within the gland. Phage K inactivation was also reported in raw milk,
likely due to the adsorption of whey proteins to the cell surface that interfere with phage
attachment (Garcia et al., 2008). However, it has been documented that a cocktail of two lytic
phages of dairy origin can successfully inhibit S. aureus in acid and enzymatic manufacturing
processes (Garcia et al., 2008).
Detection of harmful pathogens such as S. aureus at low levels is vital in industry and has a huge
environmental and economic impact. Balasubramanian et al. (2007) emphasized the use of
bacteriophage immobilization technique to detect S. aureus. In this study, a lytic bacteriophage
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was used as a highly specific and selective biorecognition element combined with a surface
Plasmon resonance-based detection sensor. The authors found a detection limit of 10,000 colony
forming units per ml, suggesting that lytic bacteriophage can be used as a probe for bacterial
detection.
Application in food industry
There are various reliable techniques that are used in present day to kill or inactivate bacterial
pathogens in food animals as well as food products including 1) antibiotics administered at
production (Zaczek et al., 2015); 2) chlorine to inactivate pathogens on various food products
including raw meat (Buncic and Sofos, 2012), fruits and vegetables (Beuchat, 2008); 3) thermal
pasteurization of liquid foods (Corry et al., 1995); and 4) food irradiation (Farkas, 1998).
However, due to continuous increase in several foodborne diseases, a possible alternative to
chemical-based bactericides might be the use of natural antimicrobials such as bacteriophage.
Contaminating bacteria can enter the food supply during slaughter, milking, fermentation,
processing, storage or packaging (Zaczek et al., 2015). Studies on bacteriophage molecular
biology have shed light on its various applications including nanotechnology, vaccine
development, therapeutic delivery, and bacterial detection systems (Summers, 2001). The
application of bacteriophages as novel, natural antimicrobials in food to inhibit undesirable
bacteria is also very promising (Garcia et al., 2008). Exploring bacteriophages as new biocontrol
agent against antibiotic-resistant bacteria has become an important topic of research with
products based on bacteriophage therapy are already available in the market (Zaczek et al.,
2015). Moreover, several companies are using bacteriophages as tools for detecting pathogens in
feed and foodstuffs. For example, the U.S. Environmental Protection Agency approved
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OmniLytics, Inc to use their product ‘Agriphage’ against plant pathogenic bacteria. In the food
manufacturing industry, Listex P100 has been approved by EBI Food Safety for controlling
Listeria in meat and cheese products. The U.S. Food and Drug Administration (FDA) in 2006
approved the use of LMP 102 (Intralytix, Inc.) targeting Listeria in ready-to-eat meat and poultry
products (Garcia et al., 2008).
The concept of fighting bacterial pathogens in food by means of bacteriophages can be addressed
at all stages of production. This can be applied in the classic “farm to fork’ concept.
Bacteriophage is suitable for enhancing microbiological safety in food because of the following
reasons: (i) it prevents or reduces the colonization of bacteria in livestock (bacteriophage
therapy); (ii) it can decontaminate carcasses and raw products, such as fruits and vegetables; (iii)
it can be used to disinfect equipment and contact surfaces (i.e. bacteriophage bio sanitation and
bio control); and (iv) it can be used to extend the shelf life of perishable manufactured foods as
natural preservatives (i.e. bio preservation) (Zaczek et al., 2015). Bacteriophage can also be used
in hurdle technology in combination with other preservation methods (Martinez et al., 2008).
Despite the advantages offered by bacteriophages, they can be commercially damaging as well.
For instance, in the fermentation industry, harmful bacteriophages are those which contaminate
the process. These bacteriophages also became a major problem in the dairy industry, causing
considerable economic losses by destroying starter cultures and disrupting fermentation
(Lawrence et al., 1976). Other industries using bacteria for fermentation have experienced losses
from bacteriophage contamination as well.
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Strategies for Controlling Staphylococcus aureus in food
It is well known that many pathogenic microorganisms such as S. aureus form biofilms on food
and food-contact surfaces under appropriate environments (Shi et al., 2009). In the food
processing environment, biofilm formation is favored by many conditions (e.g., flowing water,
suitable attachment surfaces, ample nutrients, and raw materials) (Shi et al., 2009). The time
available for biofilm formation depends on the frequency of cleaning regimes. Product contact
surfaces should typically be cleaned several times per day while environmental surfaces such as
walls may be cleaned once per week (Gibson et al., 1999). An investigation by Sharma and
Anand (2002) revealed that S. aureus could establish biofilms on the equipment surfaces of the
production lines such as pasteurization lines of dairy processing plants. Pathogenic
microorganisms can also attach to and grow on food and food contact surfaces under appropriate
environments by forming biofilms (Shi et al., 2009). A number of studies have shown that
bacterial pathogens can attach to food surfaces such as L. monocytogenes to beef surfaces
(Dickson, 1990) and Salmonella spp. to chicken skin (Campbell et al., 1987). However, humans
are the main source of transmission of these pathogens from one place to another (e.g., food
handlers contaminate food via manual contact or by coughing and sneezing). Nevertheless, in
foods such as raw meat, sausages, raw milk, and raw milk cheese, contaminations from animal
origins are more frequent and due to animal carriage or due to infections (e.g., mastitis) (Loir et
al., 2003). Therefore, it is very important to develop cleaning and disinfection methods and
control systems in food-processing plants and environments. Good Manufacturing Practice and
Hazard Analysis and Critical Control Points have been established for controlling food quality
and safety (Shi et al., 2009). Moreover, cleaning-in-place (CIP) procedures have been employed
in dairy processing lines. Some physical methods such as mechanical brushing, chemical agents
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such as detergents and biological means such as enzymes are applied to CIP procedures in order
to obtain a biofilm-free industrial environment (Shi et al., 2009). In addition, suitable contact
precautions should be taken such as using antimicrobial soap for washing hands—particularly
under fingernail area—vigorously before handling and preparing food. It is also suggested that
gloves should be worn when touching any ready-to-eat food items though this is controversial
(Herwadlt, 1999). The use of hand gloves has been much debated since it does reduce the
likelihood of transmitting bacteria from a food worker’s hand to food; however, the gloves may
pick up bacterial pathogens from food or work surfaces touched, thus significantly reducing the
effectiveness of gloves if they are worn for longer periods of time without changing (Lues et al.,
2005).
Even after using an efficient cleaning procedure, microorganisms often remain and form
biofilms on equipment surfaces (Shi et al., 2009). Residual microflora sometimes persists on
food equipment surfaces after CIP treatment (Dunsmore, 1981; Sharma and Anand, 2002).
Gibson et al. (1999) tested the resistance of biofilm to sanitizers, and they found that the
commercial products Easyclean (an alkaline detergent) and Ambersan (an acidic cleaner) were
not effective against Pseudomonas aeruginosa and S. aureus biofilms on stainless steel surfaces
(Shi et al., 2009). Therefore, novel and innovative methods should be employed in order to battle
this problem. The excessive use of chemical substances, some of which are suspect because of
their potential toxicity, has resulted in increasing pressure on food manufacturers to either
completely remove chemical preservatives from their food manufacturing systems or to adopt
more “natural” alternatives for the maintenance or extension of a product’ shelf life. There is
considerable interest in the possible use of such natural alternatives which can prevent the
growth of foodborne pathogens such as S. aureus on food products (Nychas, 2007). The
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protective and therapeutic effects of bacteriophage against a wide range of bacterial pathogens
have been well demonstrated (Monk et al., 2010). In addition, natural antimicrobials such as EOs
from plant sources can be good candidates for limiting S. aureus infections (Li et al., 2011).
More research should be done in this field so that a novel product can be developed which can
utilize the antimicrobial properties of both EOs and bacteriophage to treat infections caused by
pathogen such as S. aureus.
Research Objective
Since bacterial pathogens such as S. aureus have shown resistance against traditional
chemotherapeutic agents such as antibiotics and other disinfectants, new natural approaches to
control their growth in food and on food surfaces is pressing. In this research the possibility of
using EOs and bacteriophage alone and in combination to prevent the growth of S. aureus in
vitro has been evaluated. The hypothesis of this research is that combination of EOs and
bacteriophage will control the growth of S. aureus more effectively than either treatment
performed alone. To test this, two main objectives were set: 1) to determine the efficacy of
varying concentrations of pure EOs compounds against S. aureus and 2) to evaluate the efficacy
of a S. aureus-specific bacteriophage against S. aureus. The ultimate goal was to evaluate if the
combination of these antimicrobials has potential synergism and possible application in food
industry for controlling of S. aureus on raw chicken products.
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Chapter 2: Application of Essential Oil Compounds and Bacteriophage alone and in
combination to Control Staphylococcus aureus in vitro.
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Abstract
The present study aimed to investigate the combination of essential oils (EO) and bacteriophages
as alternative antimicrobials to control S. aureus in food. Four EO compounds were evaluated by
disc diffusion assay to determine inhibitory effects against five strains of S. aureus. Next, 48hour growth inhibition assays were performed using a 96-well bioassay. Phage adsorption assays
were performed with phage K up to 120 h at 6, 13, and 37°C to determine lytic activity.
Combinations of phage K and EOs against S. aureus were also evaluated at 37°C using a 96-well
bioassay. Disc diffusion assays indicate that the zone of inhibition (IZ) of alpha-pinene (IZ=1023mm) has a significantly higher inhibitory effect against S. aureus strains when compared to
other EOs tested. Growth inhibition assay indicated that all four S. aureus strains showed
significantly reduced growth (p < 0.006) when compared to the positive control over the 48 h
period. Alpha-pinene at 1.5% and 3.28% showed the highest significant difference for inhibition
of all S. aureus strains when compared to their respective positive controls. . Phage adsorption
assays indicate that phage K has high lytic activity at 37°C with at least a 1.5 log increase in the
number of PFU depending upon the strains when compared to 6 and 13°C, possibly impacting
applicability in food industry. With phage and EO evaluated together, all four S. aureus strains
showed a significant reduction in growth (p < 0.05) when compared to its normal growth curve.
Results from the combined effect of EO and phage indicate that the phage alone inhibits S.
aureus in vitro at 37°C as effectively as EO alone or the combination of EO and phage although
there is variability between strains. The results from disc diffusion, growth inhibition, and phage
adsorption assays indicate that EO compounds and bacteriophage can be used as antimicrobials
against S. aureus. This study provides novel findings on the antibacterial properties of pure
compounds found in crude pine oils and phage K against multiple strains of S. aureus. In
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addition, the data presented here demonstrate the potential of these natural antimicrobials as a
new approach for biocontrol of S. aureus.
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Introduction
Staphylococcus aureus is considered one of the most important pathogens and can cause
illnesses ranging from minor skin infections to life-threatening diseases such as pneumonia and
bacteremia (Yoon et al., 2013). Food production animals such as dairy cows and broiler chickens
can also be infected with S. aureus resulting in bovine mastitis and chicken arthritis
(Vanderhaeghen et al., 2010). Although these ailments are harmful to the animals, these
infections can also threaten food safety and cause food intoxications (due to production of
enterotoxins) through contamination of foods such as salads including egg, chicken or potato
salads and sandwiches which are made with hand contact and require no additional cooking.
(Gutierrez et al., 2012) Unfortunately, management of S. aureus infections in humans has
become compromised as a result of multiple antibiotic resistant strains including methicillin
resistant S. aureus (MRSA) and vancomycin resistant S. aureus (VRSA). (Panneerseelan and
Muriana, 2009).
Staphylococcus aureus is an aerobic, non-motile, non-spore forming Gram-positive bacterium. It
is a commensal colonizer of the skin, nasal passage (25 to 30% of people), and mucous
membranes (throat, axilla and rectum) of humans and warm-blooded mammals (Chao et al.,
2008). Staphylococcus aureus has the ability to grow in wide temperature ranges (4°C to 45°C),
pH levels (4 to 11), and salt concentrations (10 to 20%) allowing it to be a common foodborne
pathogen (Panneerseelan and Muriana, 2009).
Due to the resistance of S. aureus to traditional chemotherapeutic agents, researchers are now
evaluating other antimicrobial agents to fight against this pathogen such as essential oil (EO)
compounds (Nazzaro et al., 2013). Essential oils are concentrated hydrophobic liquids derived
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primarily from terpenoids (i.e. phenolic terpenes, phenylpropanoids, and alcohols) and have been
recognized for their antimicrobial properties (Bassole and Juliani, 2012). Interactions between
hydrocarbons present in EO compounds can lead to antagonistic, additive, or synergistic effects
with synergism being the most common (Ciocan et al., 2007). Essential oils are capable of
inhibiting or slowing the growth of bacteria, yeasts and molds by targeting the membrane and
cytoplasm, and in some cases, they completely change the morphology of the cells. (Nazzaro et
al., 2013). As a result, EOs and their components are widely used in medicine and food industry
as they show promising activities against many food-borne pathogens, including S. aureus, when
tested in vitro (Bassole and Juliani, 2012).
In contrast to EO compounds, lytic bacteriophage may be used as alternative antimicrobials with
enhanced specificity to the microorganisms or pathogen of interest (Rapson, 2002).
Bacteriophages are bacterial viruses that require specific receptors on the bacterial cell surface to
bind and initiate an infection (Balasubramanian et al., 2007). Their specificity for a particular
bacterial species and their lack of impact upon other micro flora make them efficient
antibacterial agents (El-Shibiny et al., 2009). With respect to S. aureus, there are several wellcharacterized lytic bacteriophage. For example, bacteriophage K has been applied in the dairy
cow industry for the elimination of bovine S. aureus intramammary infections during lactation
(Garcia et al., 2008). In general, the application of bacteriophages to control foodborne
pathogens such as S. aureus, Listeria monocytogenes, Salmonella, and Escherichia coli is
steadily growing (Hudson et al., 2010; Hagens and Loessner, 2010). For instance, bacteriophage
specific to Shiga toxin-producing E. coli (STEC) has been reported to reduce STEC on leafy
green vegetables by 3 logs (Viazis et al., 2011). Moreover, bacteriophages are now accepted as
natural food additives since they are naturally present in the digestive tract of humans and
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throughout the environment (Monk et al., 2010). Here I propose combining S. aureus-specific
bacteriophage with EOs as a way to inhibit the growth of S. aureus. Therefore, based on the
reported antimicrobial potential of both EOs and host-specific bacteriophage, I investigated the
efficacy of varying concentrations of EOs alone and in combination with S. aureus specific
bacteriophage in order to determine potential synergistic effects. More specifically, I aimed 1) to
determine the efficacy of varying concentrations of pure EOs compounds against S. aureus; 2) to
evaluate the efficacy of a S. aureus-specific bacteriophage against 4 strains of S. aureus and 3) to
combine these antimicrobials to determine potential synergism and possible application for the
control of S. aureus in vitro. The overall goal is to utilize these antimicrobial compounds for
control of S. aureus as both a nosocomial and foodborne pathogen with potential applications in
the medical industry such as the treatment of cutaneous infections caused by S. aureus as well as
the food industry.
Materials and methods
Bacterial culture
Five strains of S. aureus were maintained on tryptic soy agar (TSA, Acumedia, Lansing, MI,
U.S.). The test strains included 3 MRSA (N315, COL, Mu50), 1 susceptible (ATCC 6538;
American Type Culture Collection, Manassas, VA), and 1 susceptible clinical isolate (ASU 36)
kindly provided by Dr. Dave Gilmore at Arkansas State University, Jonesboro, AR. For each
experimental setup, one colony from each respective S. aureus strain was added to 5ml of tryptic
soy broth (TSB, Acumedia, Lansing, MI, U.S.) and incubated at 37°C for 24 h with shaking at
150 rpm. Inocula were prepared as described below for the assay to be performed.
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Disc diffusion assay
To evaluate the antimicrobial activity of four pure EO compounds against S. aureus a disc
diffusion method previously described by Muthaiyan et al. (2012) was used with modifications.
Four pure EO compounds commonly found in pine oils were used: alpha-pinene, 3-carene, (+)limonene (ACROS Organics, Morris Plains, NJ, U.S.) and (1S)-(-)-β-pinene (referred to as betapinene for remainder of manuscript) (Alfa Aesar, Ward Hill, MA, U.S.). Alpha-pinene was
evaluated alone and in combination with the three other EOs. Briefly, the overnight cultures of
each S. aureus strain were diluted separately in TSB to achieve an optical density (OD) of 0.3 at
600 nm. A 100 μl aliquot of prepared inoculum for each S. aureus strain was evenly spread on
TSA plates to create a lawn of bacteria. Sterile, blank, 6-mm paper discs (Becton, Dickinson and
Company, Sparks, MD, U.S.) were aseptically placed on TSA plates containing S. aureus and 10
µl of EO were pipetted onto the discs and allowed to absorb for 5 min. For EOs in combination,
5 μl of each EO was added to the disc. Sterile distilled water was used as a negative control.
After 24 h of incubation at 37°C, diameters (in millimeters) of zones of inhibition were measured
and recorded. The same method was followed at 6 and 13°C except lawns of S. aureus strains
were prepared at 37°C prior to addition of EO saturated discs.
Essential Oil Growth Inhibition Assay (GIA)
A growth inhibition assay was performed to evaluate the susceptibility of the S. aureus strains to
varying EO concentrations (0.5, 1.5, 3.28, and 5%) at 6, 13 and 37°C. At 37°C, a 96-well plate
bioassay and an Infinite M200 micro plate reader (TECAN, San Jose, CA, U.S.) with shaking
was used and at 6 and 13°C, a refrigerated shaker and, a spectrophotometer (Beckman Coulter
DU® 640, Brea, CA, U.S.) was used. Growth of S. aureus during exposure to the EOs was
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monitored over a 48 h period with absorbance readings (at 600 nm) recorded every 30 min when
using the micro plate reader and at 0 to every 30 min for 7 h and then at 24, 26, 28, 32, 48, 56
and 72 h when using the spectrophotometer. Essential oil solutions were prepared in four
different concentrations in 0.5% Tween 80 (Amresco, Solon, Ohio, U.S.). For the 96-well plate
bioassay, 100 μl of prepared inocula in TSB was dispensed into each well followed by 100 μl of
the EO solutions. For each S. aureus inoculum, 500 μl of overnight culture was diluted in 25 ml
of TSB to achieve an OD of 0.08 at 600 nm. Combinations of EOs were added in equal parts (50
μl + 50 μl) to achieve the same final concentration. Four controls were included in each 96-well
plate including 200 μl of prepared inoculum without EOs; 200 μl of prepared inoculum + Tween
80; 200 μl of Tween 80; and 200 μl of TSB.
GIA – Essential Oils and Phage
To evaluate the susceptibility of S. aureus to varying concentrations of EOs in combination with
phage, a 96-well plate bioassay as described above was used. All S. aureus strains were tested in
three combinations: 1) EOs alone, 2) phage alone and 3) EOs + phage along with positive and
negative controls as described above for GIA with EO only. Bacteriophage K was added at an
MOI of 0.1.
At 6 and 13°C, the GIA described previously by Muthaiyan et al. (2012) was used with
modifications. Inoculum for each S. aureus strain was prepared as described above. Individual S.
aureus strains were mixed with varying concentrations of EO compounds in 50 ml Erlenmeyer
flasks. The flasks were kept at 6 or 13°C with shaking. Growth inhibition of S. aureus at 6 and
13°C was monitored at regular intervals. A negative control flask of bacterial culture without EO
was included.
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Bacteriophage Characterization
Preparation of phage stock
Two strains of bacteriophage, bacteriophage K (ATCC 19685-B1) and bacteriophage 92 (ATCC
33741-B1) were initially used. A double overlay method was used to propagate the
bacteriophage. Briefly, for propagation of bacteriophage K, 100 µl log phase S. aureus culture
(ATCC 25923) was combined with 100 µl bacteriophage K in 5 ml of 0.7% TSA (soft agar). The
soft agar was poured on TSA plates, allowed to solidify, and the plates were incubated at 37°C
for 24 hours to allow for complete lysis of the bacterial lawn. After 24 hours, the soft agar was
scraped off and placed in a 50 ml conical tube containing 15 ml of SM buffer (5.8 g NaCl, 1.2 g
MgSO4, 50 mL 1M Tris-HCl (pH 7.5), 0.1 g Gelatin) and vortexed. The bacteriophage
suspension was then kept in an incubator at 37°C with gentle shaking for 4 hours. The
suspension was centrifuged at 580 × g for 25 min at 4°C to sediment the cellular debris and agar.
The clear supernatant containing bacteriophage K was collected and passed through a 0.22 µm
pore size cellulose acetate filter (VWR, Radnor, PA, U.S.) to obtain a homogenous phage stock.
The concentration of bacteriophage K stock was determined using the double agar overlay
method described above. Following titration, the bacteriophage K stock was stored in small
aliquots at −80°C. For bacteriophage 92, the above method was followed with the exception of
using nutrient broth (NB, Becton, Dickinson & Company, Annapolis, MD, U.S.) with 400µg/ml
of CaCl2.
Phage adsorption
To evaluate adsorption properties of bacteriophage K and 92, phage adsorption assay as
described previously by Hwang et al. (2009) was used with modifications. Briefly, S. aureus
38

strains were prepared in TSB with a final concentration of 108 CFU/ml. Bacteriophage K or 92
was added to the cell suspension at a MOI of 0.1 (107 PFU/ml) and incubated at 37°C to allow
adsorption to the bacterial cells. At time 0 and every 10 min for 1 h, phage-bacteria suspensions
were collected and centrifuged at 14,000 × g for 10 minutes. The supernatant was decanted and
serially diluted. Plaque assay using the double overlay method as described above was used to
determine the number of bacteriophage in the supernatant and reported as plaque forming units
(PFU).
Inhibition of S. aureus in vitro
Each S. aureus inoculum was mixed with bacteriophage K at a MOI of 0.1. At the designated
time points (e.g., time 0 followed by every hour for 6 h, then at 24, 48, 72, 96 and 120 h), the OD
at 600 nm was measured, and the sample was processed for recovery and detection of
bacteriophage as described above in bacteriophage-adsorption. Inactivation of S. aureus by
bacteriophage K was performed at 6, 13, and 37°C.
Effect of essential oils on phage
The inhibitory effect of EOs on bacteriophage K was examined. Bacteriophage inhibition was
measured at 6, 13, and 25°C for designated time points (0, 1, 6, and 24 h). Briefly, bacteriophage
suspension was mixed with EOs at select concentrations and incubated at the appropriate
temperature. A double overlay assay was performed to determine the effect of EOs against
bacteriophage K using S. aureus host ATCC 25924.
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Statistical Analysis
All experiments were repeated two times with duplicate plates. Before analysis, the mean of the
duplicate plate counts from two replicates was converted to log10 PFU/ml. For disc diffusion
assay, differences between means of zone of inhibitions were tested by least square difference,
and statistical differences were examined using two factor factorial and randomized complete
block diagram (RCBD). Population of S. aureus strains treated with bacteriophage-EOs cocktail
were subjected to one-way analysis of variance (ANOVA) for a completely randomized design
using JMP (Version 11.1.1, SAS Institute Inc., Cary, NC) to determine whether treatment with
bacteriophage-EO significantly reduced the number of viable S. aureus cells. In all cases, the
level of statistical significance was set at P < 0.05.
Results
Disc diffusion assay
The antimicrobial effects of EOs against five S. aureus strains based on the disc diffusion assay
are shown in Table 1. All five S. aureus strains showed varied susceptibility to the EO
compounds at 37°C with zones of inhibition (IZ) ranging from 8 to 23 mm in diameter. More
specifically, alpha-pinene alone had significantly higher inhibitory effect against S. aureus
strains (IZ = 10 to 23 mm) when compared to the use of the EO compounds in combination
(Figure 1). This can probably be explained by the fact that 10 µl of each compound were used
when evaluated alone whereas 5 µl of each compound was used when evaluated in combination.
In addition, Mu50 strain was the least susceptible to the majority of EO compounds and thus was
excluded from future experiments. With respect to EOs in combination, greater antimicrobial
effects were observed with alpha-pinene + (+)-limonene (IZ =11 to 15 mm) when compared to
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alpha-pinene used in combination with beta-pinene and 3-carene. Within S. aureus strains, COL
had significantly different IZ with each of the four EO compounds (Table 1). Within EO
compounds, all except alpha-pinene + (+)-limonene produced significantly different IZ across all
five strains of S. aureus (Table 1).
In addition to 37°C, the antimicrobial properties of these EO compounds were also tested at 6
and 13°C. These temperatures were selected because it represents refrigeration temperature and
temperature abuse of food products, respectively, in order to evaluate potential application in the
food industry. However, the disc diffusion assay was not suitable for evaluation at these
temperatures since lawns of S. aureus strains first had to be prepared at 37°C prior to addition of
EO compounds which is counter indicative for this method (data not shown).
Efficacy of essential oils against S. aureus
To evaluate the inhibitory effect of EO compounds, growth inhibition assays were performed by
exposing four S. aureus strains to various EO concentrations (0.5%, 1.5%, 3.28%, and 5%) over
a 48-hour period at 37°C. All four S. aureus strains showed significantly reduced growth (p <
0.006) when compared to the positive control over the 48 h period (Figure 2). As expected, the
lowest concentration of EO (0.5%) had the least inhibitory properties against S. aureus growth
when compared to subsequently higher concentrations. Conversely, higher concentrations of EO
(3.28% and 5%) showed similar results with inhibition to S. aureus up to 48 hours depending on
the strain. Similar to the disc diffusion assay, alpha-pinene showed higher inhibition of S. aureus
growth when compared to the EOs in combination. However, out of the EO combinations
evaluated, alpha-pinene + 3-carene inhibited S. aureus growth better than the other combined
EOs. Alpha-pinene at 1.5% and 3.28% showed the highest significant difference for inhibition of
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all S. aureus strains with p-values ranging between 0.0006 to 0.001 when compared to their
respective positive controls. Based on these results, 1.5% and 3.28% concentrations of alphapinene alone and alpha-pinene + 3-carene were selected for further evaluation. The results of the
growth inhibition assay with alpha-pinene alone and alpha-pinene + 3-carene at concentrations of
1.5% and 3.28% against four S. aureus strains are shown in Figure 2.
Phage characterization
The lytic activity of the two S. aureus specific bacteriophage, bacteriophage K and 92 were
tested against S. aureus strains. All five S. aureus were weakly susceptible towards
bacteriophage 92 and thus the adsorption of the bacteriophage to the S. aureus strains was
relatively low resulting in very few PFU (data not shown). Therefore, bacteriophage 92 was
excluded from further experiments. Conversely, bacteriophage K showed high lytic activity
against all S. aureus strains tested (Figure 3). For phage adsorption at 37°C, bacteriophage K
showed a steady increase in the number of PFU over a period of 6 hours when incubated with all
S. aureus strains (Figure 4C). After 6 hours at 37°C, S. aureus strains ASU 36 and ATCC 6538
had more than a 2 log increase in the number of PFU, and S. aureus strains N315 and COL
showed more than a 1.5 log increase in the number of PFU. At 6 and 13°C, the lytic activity of
bacteriophage K gradually decreased over the 6 h period against S. aureus strains (Figure 4A-B).
To investigate the antimicrobial activity of bacteriophage K over a prolonged period of time (24
to 120 hours), phage adsorption was performed at 6, 13, and 37°C (Figure 5A-C). At 6°C, the
replication of bacteriophage K in all S. aureus strains showed fluctuations in number of PFU
before decreasing after 120 hours. At 13°C, the number of PFU remained more or less constant
after 72 hours, ranging between 4 and 6 log10 PFU/ml depending on the strain (Figure 5B). As
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expected, at 37°C the number of PFU was 3 log higher after 24 hours as compared to 6 and 13°C
(Figure 5). The lytic activity of bacteriophage K against S. aureus strain COL remained constant
over a period of 120 hours. For other strains, the number of PFU slightly decreased after 72
hours. In addition to direct count of PFU, OD readings were also measured prior to
centrifugation to collect PFU; however, the pattern of OD readings varied with different strains
and did not often correspond with PFU/ml (data not shown).
Efficacy of combined phage and EO against S. aureus
To evaluate the inhibitory effect of EO compounds (α-pinene and 3-carene) combined with
bacteriophage K, GIAs were performed by exposing four S. aureus strains to two concentrations
(1.5% and 3.28%) of EO as well as bacteriophage K at a MOI of 1 over a 48-hour period at
37°C. All four S. aureus strains showed a significant reduction in growth (p < 0.05) when
compared to its normal growth curve (Figure 6A-D). Both bacteriophage K alone and α-pinene
alone at 1.5% and 3.28% showed similar inhibition trends as observed in phage adsorption and
initial GIAs against all S. aureus strains, respectively. However, with bacteriophage K and EO
combinations, bacteriophage K with 3.28% α-pinene inhibited S. aureus growth better than other
combinations of EOs and bacteriophage depending upon the strain. For S. aureus strains N315
and ASU 36, there was no significant difference between the treatments. For COL and ATCC
6538, bacteriophage K had significantly higher inhibitory effect compared to other treatments
such as 1.5% α-pinene and bacteriophage K + 1.5% α-pinene (p value ranging between 0.006 to
0.021) (Figure 6C). The results of the GIAs with α-pinene and bacteriophage K alone and in
combination at concentrations of 1.5% and 3.28% against four S. aureus strains are shown in
Figure 6A through 6D.
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Discussion
Staphylococcus aureus is one of the major bacterial agents causing foodborne diseases in
humans primarily through the production of enterotoxins. In addition to this, S. aureus is also the
most common nosocomial pathogen according to the National Nosocomial Infections
Surveillance (Wunderink et al., 2003). Humans are common asymptomatic carriers of
enterotoxigenic S. aureus in the nose, throat, and skin. (Gutierrez et al., 2012). Since S. aureus is
becoming universally resistant to traditional chemotherapeutic agents, there is more focus on the
pre-antibiotic era for alternative antimicrobials effective against S. aureus including EOs and
bacteriophage (Panneerseelan and Muriana, 2009).
In the present study, I evaluated the antimicrobial activity of four pure EO compounds that are
common components of crude essential oils including those extracted from coniferous trees (e.g.,
loblolly pine or Pinus taeda L.), rosemary, citrus fruits, and cumin (Fu et al., 2007; Allahghadri
et al., 2010). I focused on pure compounds from pine oils as a recent paper by Adams et al.,
(2014) determined that α-pinene, β-pinene, and limonene were major components in crude oils
extracted from the loblolly pine, a major forestry product of Arkansas in the U.S. The study by
Adams et al. (2014) also indicated some antimicrobial activity of the crude essential oil extracts
against S. aureus; therefore, in the present study, I aimed to evaluate some of the major
components separately and in combination.
Numerous studies have evaluated the efficacy of a variety of EO compounds against bacterial
pathogens in vitro including S. aureus. These EOs include bay, cinnamon, clove, lemongrass,
lemon myrtle, mountain savory, Melissa, ajwaine oil, bavchi oil and oregano (Adukwu et al.,
2012; Hyun et al., 2014; Palmer et al., 1998 Upadhyay et al., 2010; Chao et al., 2008 and
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Leuschner and Lelsch, 2003). Palmer et al. (1998) investigated the antimicrobial activity of 21
plant essential oils against S. aureus. The authors reported that oils such as bay, cinnamon, clove,
spearmint, thyme and eucalyptus had a high bacteriostatic and bactericidal effect against S.
aureus with a zone of inhibition ranging from 8 to 11mm (disc diameter 4 mm) as compared to
other plant essential oils tested. Another study by Adukwu et al. (2012) reported that low
concentrations of lemongrass EO (0.03 to 0.06%, v/v) effectively inhibited the growth of S.
aureus and was bactericidal at slightly higher concentrations (0.125%). Meanwhile, in the same
study, the effective inhibitory and bactericidal concentrations of grapefruit EO against S. aureus
were reported to be 10 to 100-fold higher than lemongrass. These results indicate that some EOs
are effective at very low concentrations while others are effective at relatively higher
concentrations. Therefore, in this study, I selected a range of concentrations (0.5, 1.5, 3.28 and
5%) to better understand the effect of the components of pine EO against S. aureus. To date,
there are very few studies that have investigated the antimicrobial activity of pine EO and its
individual components against bacterial pathogens.
Of direct relevance to the present study, Hong et al. (2004) reported that the EOs of pine needles
exert antibacterial effects against L. monocytogenes, S. aureus, and Klebsiella pneumoniae with
the zone of inhibition diameter in the range 11 to 14 mm. In the present study, the S. aureus
strains showed varied zones of inhibition (IZ) to the EOs evaluated ranging from 8 to 23 mm in
diameter. Palmer et al. (1998) studied the inhibitory effects of clove and rosemary EOs against S.
aureus and reported IZ of 8 and 5.9 mm, respectively. Fu et al. (2007) investigated the same EOs
for antimicrobial effects against S. aureus and observed zones of inhibition of 16.3 ± 0.7 and
18.5 ± 1.3 mm, respectively. Although these two studies used different diameter discs—4 mm
and 6 mm—the differences in the outcomes of these studies show that the disc diffusion assay
45

can result in varied outcomes when the same EOs are evaluated. In this study, I also evaluated
the inhibitory effect of trans-cinnamaldehyde on S. aureus. The S. aureus strains showed a
higher susceptibility towards trans-cinnamaldehyde as compared to pine EO compounds with IZ
ranging from 28-44 mm in diameter. In order to investigate differences in IZ that might result
from the use of different media, disc diffusion assay using trans-cinnamaldehyde was also
performed on CHROMagar Staph aureus (CHROMagar, Springfield, NJ, U.S.) plates and TSA
plates using the same method. Comparison between TSA and CHROMagar plates indicated that
the IZ produced by trans-cinnamaldehyde on CHROMagar plates were slightly larger than the IZ
produced on TSA plates (data not shown). This is evidence of the variability the disc diffusion
assay can have with only a change in media thus indicating that this is truly a crude screening
method.
A novel aspect of the present study was the evaluation of combinations of pure EO compounds.
Different terpenoid components of EOs can interact to either reduce or enhance antimicrobial
efficacy (Delaquis et al., 2002). Synergism is observed when the effect of the combined
substances is greater than the sum of the individual effects (Burt, 2004) while the absence of
interaction is defined as indifference. Interestingly, phenolic monoterpenes and phenylpropanoid
which typically show strong antimicrobial activities in combination with other components were
found to increase the bioactivities of these mixtures. For instance, mixtures of menthol with
geraniol yielded synergistic effects against S. aureus (Gallucci et al., 2009). Other monoterpenes
have also been tested such as the oxide 1, 8-cineole in combination with aromadendrene and
limonene and were found to have additive and synergistic effects against S. aureus, respectively
(Mulyaningsih et al., 2010; van Vuuren and Viljoen, 2007). According to Tserennadmid et al.
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(2011), monoterpene hydrocarbons (e.g., α-pinene) when combined with limonene or linalool
exhibited synergistic effects against yeast.
Mixtures of crude EOs have also been shown to interact with each other acting as additive,
synergistic, and antagonistic agents (Kim et al., 1995). The EOs of basil (Ocimum basilicum) and
peppermint (Mentha piperita) were shown to have synergistic effect against S. aureus, E. coli,
and S. Typhimurium when used in combination (Bassole et al., 2012). In the same study, two
lemon grass EOs, Cymbopogon citratus and C. giganteus, exhibited additive effects against S.
aureus, E. coli, L. monocytogenes, and S. Typhimurium. Conversely, antagonistic effects have
also been reported when antimicrobials are combined. Van Vuuren and Viljoen (2007) combined
Melaleuca alternifolia EO (i.e. tea tree oil) and ciprofloxacin and reported an antagonistic effect
against S. aureus. In the present study, the aim was to test the relationship (additive, synergistic
or antagonistic) between pure EO compounds found in pine. The data indicate that EOs at
different concentrations showed varied levels of inhibition against S. aureus, and in most cases,
the combined EOs exhibited an additive effect against S. aureus. Here, the antimicrobial
properties of S. aureus-specific bacteriophage were also investigated. Bacteriophage therapy is
suggested as an alternative to treat bacterial infections due to its effectiveness against multidrugresistant bacteria (e.g., MRSA), low cost, and self-replicative mode of action (Wang et al.,
2010). Capparelli et al. (2007) investigated the effectiveness of a S. aureus specific
bacteriophage against MRSA in a mouse model and reported that 100% of the mice receiving
bacteriophage therapy for treatment of MRSA infection survived compared to 20% for the
control group. Although bacteriophage therapy is most often associated with investigating
treatments for clinical infections—human and animal (Capparelli et al., 2007.) One of the aims
of the present study was to understand the potential application of bacteriophage for control of
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pathogens in other settings such as the food industry. More specifically, bacteriophage may be
used as bio control agents during industrial food processing to reduce colonization of pathogens
by application to food surfaces such as meats and fresh produce and through mixing with
processed foods or even raw milk. However, a study by Goode et al. (2003) observed that
bacteriophages are very effective against actively growing bacteria, but lose effectiveness in
metabolically inactive bacteria which may be problematic in the food industry. Conversely,
Greer (1998) reported that bacteriophage may continue to display lytic activity at temperatures as
low as 1°C. Moreover, once foods are moved to room temperature, bacteriophage are capable of
further controlling bacterial proliferation (Bigwood et al., 2008). For instance, Abuladze et al.
(2008) evaluated the effectiveness of a cocktail of bacteriophage in the reduction of E. coli
O157:H7 on vegetables. The authors reported that the bacteriophage cocktail reduced bacterial
contamination on broccoli samples by 99.5%, 99% and 97% during storage at 10°C for 24, 120,
and 168 h, respectively. Additional evidence of bacteriophage application in the food industry
include Salmonella-specific bacteriophage applied to raw meats, ready-to-eat (RTE) foods, and
fresh produce (Guenther et al., 2012); S. aureus-specific bacteriophage use during cheese
manufacturing (Bueno et al., 2012); and commercially available bacteriophage cocktails (e.g.,
Listex™ P100 and ListShield™) for control of L. monocytogenes in raw and RTE foods (Soni et
al., 2010).
In the present study, bacteriophage K was shown to effectively reduce S. aureus concentrations
in vitro at various temperatures with the greatest antimicrobial effect shown at 37°C. Additive or
synergistic effects of the combination of bacteriophage K and pine-derived EO compounds
against S. aureus were also investigated. To my knowledge, only a single previous study has
considered the potential synergism between bacteriophage and EO.
48

Viazis et al. (2011)

investigated the potential synergism between E. coli O157:H7-specific bacteriophage and transcinnamaldehyde when applied to fresh produce. The authors observed at least a 1 log CFU
reduction in the number of E. coli O157:H7 on organic baby spinach and baby romaine lettuce
leaves after treatment with the combination of bacteriophage and EO suggesting a potential
additive or even synergistic effect since the combination was more effective than either treatment
alone. Additional studies have investigated the combination of bacteriophage with other
antimicrobials such as nisin and bacterial strains exhibiting antagonistic activity towards
pathogens (Martínez et al., 2008; Guenther et al., 2012; Table et al., 2012)
The primary aim of this study was to understand combined effects of S. aureus specific
bacteriophages with various EO compounds of pine oil against the growth of S. aureus. The data
presented in this study proved that S. aureus specific bacteriophages combined with pine EO
compounds is a potential method to control S. aureus in vitro. Unfortunately, the antimicrobial
activity of both bacteriophage and EO is temperature dependent. In this study, the antimicrobial
activity of EO at low temperatures did not yield successful results. It was noted that application
of pine EO compounds (α-pinene) and bacteriophage K together resulted in higher reduction of
S. aureus in vitro as compared to when applied alone. Thus, using bacteriophages in combination
with EO to reduce growth of bacterial pathogens such as S. aureus, has the potential to be a
novel approach for inhibiting S. aureus in various settings including clinical and within the food
industry.
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Table 1: Zone of inhibition (mm) by essential oil compounds against S. aureus strains at 37°C.

Zone of inhibition (mm)
S.
aureus
α-pinene +
α-pinene
strains
β-pinene
a,x
ATCC 6538
23(3.22)
10(1.4)b,x

α-pinene +
3 carene
14(1.96)c,x

α- pinene
Limonene
11(1.54)b,x

ASU 36

18(2.52)a,y

12(1.68)b,y

14(1.96)c,x

14(1.96)c,y

COL

19(2.66)a,y

9(1.26)b,x

12(1.68)c,y

14(1.96)d,y

N315

18(2.52)a,y

11(1.54)b,y

12)(1.68)b,y

15(2.1)c,y

Mu50

10(1.4)a,z

8(1.12)b,z

9(1.26)b,z

11(1.54)a,x

x-z

Means in the same column are significantly different (p< 0.05).

a-d

Means in the same rows are significantly different (p< 0.05).

Values in parenthesis are standard deviation observed.
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A

B

Figure 1. Disc diffusion assay. Susceptibility of S. aureus strains to (A) alpha-pinene and (B)
alpha-pinene + 3-carene.
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B
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D

C

Figure 2. Growth inhibition assay with two essential oil compounds at 1.5% and 3.28%
concentrations against four S. aureus strains (A) ASU 36, (B) ATCC 6538, (C) COL and (D)
N315. Line styles used in the graph are indexed as follows:
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Figure 3. Phage adsorption assay with bacteriophage K and S. aureus strains at 37°C. Four
strains are indicated by
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A

B

C

Figure 4. Phage adsorption assay of bacteriophage-bacteria suspension at various time points and
three different temperatures; (A) 6°C (B) 13°C and (C) 37°C. Four strains are indicated by
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A

B

C

Figure 5. Phage adsorption assay with bacteriophage K and S. aureus strains at (A) 6°C, (B)
13°C and (C) 37°C. Four strains show up as
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A

B

C

D

Figure. 6 Growth inhibition assay with bacteriophage K and two concentrations (1.5% and
3.28%) of essential oil compound α-pinene alone and in combination against four S. aureus
strains (A) N315 (B) ASU36, (C) COL and (D) ATCC 6538. Line styles used in the graph are
indexed as follows:
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Chapter 3: Application of bacteriophage and essential oils for the control of Staphylococcus
aureus on raw chicken products
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Abstract
Multidrug-resistant (MDR) Staphylococcus aureus are increasingly prevalent and combinations
of different antimicrobials represent an approach for combating MDR bacteria. Antimicrobials
with potential food industry application include essential oils (EO) and bacteriophage. The aim
of the present study was to investigate the combination of EOs and bacteriophages as alternative
antimicrobials to control S. aureus on the surface of raw chicken products. To evaluate
effectiveness on meat products, 2 cm × 2 cm pieces of chicken breast were inoculated with a 3 ×
107 CFU of a four strain cocktail of S. aureus followed by addition of bacteriophage alone, EO
alone, or bacteriophage and EO in combination. Chicken pieces were incubated at 6, 13, and
25°C, and samples were collected over time to measure reduction in S. aureus by bacterial
spread plate method. Results indicate that at 25°C bacteriophage K alone inhibits S. aureus
growth better as compared to other antimicrobial combination though these differences were not
statistically significant. At 6 and 13°C, there was no significant effect of EO and bacteriophage
alone or in combination against S. aureus when applied on the raw chicken pieces. Previous
studies indicate that EOs and bacteriophage can be used as potential antimicrobials against S.
aureus in vitro. However, for these antimicrobials to work in situ such as on raw meat products,
a better delivery method should be employed for a uniform application on meat.

64

Introduction
Staphylococcus aureus is commensal on human skin and is an important human pathogen
causing illnesses ranging from minor skin infections to life-threatening diseases such as
pneumonia and bacteremia (Yoon et al., 2013). Food production animals such as chickens and
pigs can also become infected with S. aureus resulting in bovine mastitis and chicken arthritis
which can also threaten food safety and potentially cause food poisoning (Vanderhaeghen et al.,
2010). Multiple antibiotic resistance is becoming a serious issue in the management of S. aureus
infections. Since few new antibiotics have been placed on the market since 1998 and there are
fewer prospects for new antibiotic agents, future treatments may depend on researching
alternative therapies (Rapson, 2002). Research has revealed some promising novel antimicrobial
candidates including plant essential oils (EO) and host-specific bacteriophage (Chao et al.,
2008).
The application of bacteriophages to control the growth of foodborne pathogens such as S.
aureus, Listeria monocytogenes, Salmonella enterica, and Escherichia coli is steadily growing
(Hudson et al., 2010; Hagens and Loessner, 2010). For the purpose of the present study, the
focus will be on bacteriophage specific to S. aureus. Staphylococcus aureus bacteriophages are
grouped into three classes based on genomic size: class I (<20kb), class II (~40kb) and class III
(>125 kb) (Kwan et al., 2005). Bacteriophages belonging to class III are obligate lytic
bacteriophages with relatively wide host ranges. For example, bacteriophage K—the
bacteriophage used in the present study—belongs to class III (127 kb) (Kwan et al., 2005).
Obligate lytic bacteriophages have received renewed interest as potential therapeutic agents to
replace or supplement antibiotics in the treatment of methicillin resistant S. aureus (MRSA) or
other antibiotic-resistant S. aureus strains (Yoon et al., 2013). Bacteriophages have also been
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developed as a food surface decontaminant for other foodborne pathogens including Listeria, E.
coli, and Salmonella (e.g. Listex P100, EcoShield, and SalmoFresh) (Soni et al., 2010). The
acceptance of bacteriophages as natural food additives is based on the presence of naturally high
levels of bacteriophages in the digestive tract of humans and throughout the environment. (Monk
et al., 2010).
In vitro data indicate that many plant-derived EOs have antimicrobial activity. For instance,
forestry by-products such as turpentine have been used topically as a medicinal for centuries for
treating human parasites and even a modern day vapor rub (i.e. Vicks®) for treating congestion
and coughs contains turpentine (Hoon et al., 2004). According to Dryden et al. (2004), topical
tea tree oil is an effective therapy for reducing MRSA nasal colonization. Antimicrobial
components of Pelargonium EOs (i.e. citral and linalool) have been found to be effective against
S. aureus and could be used as a novel food or cosmetic antimicrobial agents (Lis Balchin et al.,
1998). Adukwu et al. (2012) also reported that lemongrass EO at low concentrations (0.03 and
0.06% (v/v)) was effective at inhibiting the growth of S. aureus strains in vitro.
With respect to application of bacteriophage in food products, the use of bacteriophages for
reduction of Campylobacter on meat products has been extensively investigated. For example,
Bigwood et al. (2008) reported that Campylobacter-specific bacteriophage reduced C. jejuni
inoculated on cooked and raw meat at 5°C and 24°C, by 2.4 log10 CFU/cm2 and 1.5 log10
CFU/cm2, respectively. Additional applications of bacteriophage in food products have also been
reported (Zaczek et al., 2015). Viazis et al. (2011) reported that E. coli O157:H7 specific
bacteriophages significantly reduced the number of E. coli O157:H7 cells on baby romaine
lettuce leaves. In addition, Salmonella bacteriophages (SSP5 and SSP6) have been shown to
control Salmonella on alfalfa seeds (Kocharunchitt et al., 2009) while Listeria bacteriophages
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were reported to suppress the growth of L. monocytogenes on honeydew melon (Leverentz et al.,
2004).
Numerous studies have reported on the prevalence of various human pathogens including S.
aureus on meat products. Waters et al., (2011) investigated the prevalence of S. aureus in U.S.
meat and poultry samples (n = 136). Staphylococcus aureus contamination was most common
among turkey samples (77%), followed by pork (42%), chicken (41%) and beef (37%).
Similarly, Weese et al. (2010) reported the isolation of MRSA from 7.7% of pork samples tested
(31/402). In another study by Hanson et al. (2011), S. aureus was isolated from 27 of 165 meat
samples (i.e. turkey, pork, chicken, beef) from retail stores in Iowa with the highest prevalence in
turkey (19.4%), pork (18.2%), and chicken (17.8%). Incidence of S. aureus on retail meat
including MRSA have been reported in various other studies as well (Pu et al., 2008; Bhargava
et al., 2011 and O’Brien et al., 2012). However, it is still unknown whether MRSA
contamination of raw meats can play any role in the overall ecology and transmission of this
organism (O’Brien et al., 2012).
To control the potential regrowth of pathogens in food products, more specifically meat and
poultry products, a combined bacteriophage and EO treatment may offer a more practical and
cost-effective approach. Since bacteriophages are present in almost every environment and EOs
can be easily extracted from plants, these antimicrobials tend to be less expensive than many
antimicrobials on the market (Viazis et al., 2011). Both bacteriophages and EOs have been
successfully applied to suppress the activity of food borne pathogens. For instance, Viazis et al.
(2011) reported that the combination of E. coli O157:H7 specific bacteriophage BEC8 and the
EO trans-cinnamaldehyde lead to complete inactivation (5 log CFU/leaf reduction) of E. coli
O157:H7 within 10 minutes and 1 hour at all temperatures (4, 8, 23, and 37°C) for spinach and
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lettuce, respectively. The bacteriophage treatment is a new and effective hurdle, which if applied
with EOs may maximize the protection from food borne pathogens on both raw and processed
food products.
Since EOs have the potential to be used as natural agents for food preservation due to their
content of antimicrobial compounds (Helander et al., 1998) and bacteriophages offer a natural
method to control bacterial contamination of foods (Callaway et al., 2008), using a combination
of these treatments may prove more beneficial as it may produce additive or synergistic effects.
The multiplicity of infection (MOI) is considered to be a key parameter in bacteriophage
application to food surfaces (Viazis et al., 2011). Hudson et al., (2013) reported that increasing
bacteriophage concentrations result in greater reductions in the concentration of pathogenic
bacteria. Therefore, with this proposed hurdle technology (i.e., bacteriophage combined with
EO), lower concentrations of each antimicrobial could be employed in a specific sequence to get
similar or better results than either alone and maximize protection from foodborne pathogens
such as S. aureus on meat products can be achieved. Another advantage of using a combined
treatment is overcoming the limitations of EO and bacteriophages when used separately. For
instance, occurrence of bacteriophage resistance within bacterial populations can limit
bacteriophage application in the food industry (Ye et al., 2010). Additionally, EOs can exhibit
poor inhibitory effects against S. aureus at lower temperatures (6 and 13°C). To overcome the
limited efficacy of bacteriophages and EO as antimicrobials used separately, this study
investigates the effectiveness of their combined use against S. aureus on raw chicken products.
Material and Methods
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Preparation of meat
Chicken breasts were purchased from a retail grocery store in Fayetteville, Arkansas. Packaging
was removed using a razor blade sterilized with 10% bleach, and chicken breasts were
transferred into individual zip lock bags and stored at -18°C for a maximum of 4 weeks and,
before use, thawed and all excess liquid was removed. Raw chicken pieces were sliced
aseptically into thin 2cm x 2cm squares using a sterile knife. The knife was sterilized with 70%
ethyl alcohol followed by 10% bleach. The chicken pieces were then placed individually into
pre-labeled Petri dishes and equilibrated to 6°C, 13°C, and 25°C for two hours prior to
inoculation with S. aureus cocktail.
Preparation of bacterial stocks
Inocula of individual S. aureus strains (N315, ASU 36, ATCC 6538 and COL) were grown in
tryptic soy broth (TSB, Acumedia, Lansing, MI, U.S.) overnight at 37°C with shaking at 150
rpm. Enumeration of each S. aureus strain was performed to determine the final concentration. A
S. aureus cocktail was prepared by mixing 1 ml from each overnight grown culture strain. Serial
dilution and spread plating on tryptic soy agar (TSA, Acumedia, Lansing, MI, USA) plates was
performed to determine the overall stock concentration of the cocktail (1.5 × 109 CFU/ml).
Preparation of bacteriophage K
Propagation of high titer stocks of bacteriophage K was carried out using double overlay method
with S. aureus ATCC 25923 as host as described in Chapter 2. Briefly, for propagation of
bacteriophage K, 100 µl of a log phase S. aureus culture was combined with 100 µl
bacteriophage K (1011 PFU/ml) in 5 ml of 0.7% TSA (soft agar). The soft agar was poured on
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TSA plates, allowed to solidify, and the plates were incubated at 37°C for 24 h to allow for
complete lysis of the bacterial lawn. After 24 h, the soft agar was scraped off and placed in a 50
ml conical tube containing 15 ml of SM buffer (5.8 g NaCl, 1.2 g MgSO4, 50 ml 1M Tris-HCl
(pH 7.5), 0.1 g Gelatin) and vortexed for 2 min. The bacteriophage-SM buffer suspension was
then kept in an incubator at 37°C with gentle shaking for 4 hours. The suspension was
centrifuged at 580 × g for 25 min at 4°C to sediment the cellular debris and agar. The clear
supernatant containing bacteriophage K was collected and passed through a 0.22 µm pore size
cellulose acetate filter (VWR, Radnor, PA, U.S.) to obtain a homogenous bacteriophage stock.
The concentration of bacteriophage K stock was determined using the double agar overlay
method. Following titration, the bacteriophage K stock was stored in small aliquots at −80°C.
The bacteriophage K stock concentration was 1 × 1011 PFU/ml which was diluted to 1 × 108
PFU/ml using sterile 1× phosphate buffered saline (PBS). The bacteriophage K was added at
MOI 0.1 with a final concentration of 2 ×106 PFU/20µl. Based on our previous bacteriophage
adsorption studies (Chapter 2), bacteriophage K resulted in greater lytic activity against S. aureus
strains at a MOI of 0.1 as compared to a MOI of 0.01 and 1.
Preparation of essential oil
Two EO compounds were selected for this study—alpha-pinene and 3-carene (ACROS
Organics, Morris Plains, NJ, U.S.). Essential oil solutions were prepared in two different
concentrations (1.5% and 3.28%) in 0.5% Tween 80 (Amresco, Solon, Ohio, U.S.). Based on our
previous growth inhibition studies, 1.5% and 3.28% of alpha-pinene alone and alpha-pinene + 3carene showed the highest inhibitory effect against all S. aureus strains compared to other
treatments (Chapter 2).
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Treatment of inoculated meat product with bacteriophage and/or EOs
For experimental samples, 20µl aliquots of exponential phase S. aureus host cocktail containing
approximately 3×107 cells total were carefully pipetted onto the upper surface of the 2 cm × 2 cm
raw chicken piece and allowed to dry for 10 min at room temperature for maximum adhesion to
the food matrix. Each sample of chicken was then treated with a 20µl solution of either
bacteriophage with a MOI of 0.1 or EO diluted (1.5 or 3.28%) suspension. To examine the
combined effect of bacteriophage K and EO on chicken pieces inoculated with S. aureus, 10µl of
each antimicrobial solution was pipetted onto the inoculated surface of the chicken to give the
same final concentrations at the treatments alone. For control samples, a positive control with the
same concentration of S. aureus cocktail was used without addition of bacteriophage and/or EO
suspension. Chicken pieces inoculated with 20µl of PBS and/or 0.5% Tween 80 were used as
negative controls. After adding S. aureus cocktail and the appropriate antimicrobial treatment
(phage and/or EO), the individual Petri dishes were incubated at 6, 13, and 25°C for varying time
periods depending upon the temperature.
Enumeration of bacteria on meat products
For enumeration of S. aureus, chicken pieces were individually transferred to sterile Whirl-Pak
bags (Nasco, Fort Atkinson, WI, U.S.). Five ml of PBS were added to the sample using a sterile
serological pipet. Samples were then mixed vigorously by hand for two min. The liquid portion
was transferred to a sterile 14 ml culture tube and vortexed for 20 s. After vortexing, 1 ml of the
eluent was transferred to a micro centrifuge tube and centrifuged at 14,000 × g for 10 min. The
supernatant was removed and the pellet was re-suspended in 1ml of PBS. The re-suspended
pellet was then prepared in 10-fold dilutions in PBS and the appropriate dilution was applied to
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CHROMagar Staph aureus plates (CHROMagar, Springfield, NJ, U.S.) using the spread plate
method for enumeration of S. aureus at different time points (0, 1, 6, 24, 48, 72, 96 and 120 h).
The plates were incubated at 37°C for 24 h. Each experiment was carried out in duplicate on two
separate occasions.
Statistical Analysis
All experiments were repeated two times with duplicate plates. Population of S. aureus strains
treated with bacteriophage and/or EOs solution was subjected to one-way analysis of variance
(ANOVA) using JMP (Version 11.1.1, SAS Institute Inc., Cary, NC, U.S.) to determine whether
treatment with bacteriophage and/or EO significantly reduced the number of viable S. aureus
cells on raw chicken product. Results were considered significantly different at p 0.05.
Results
The antimicrobial treatments alone and in combination were tested against a cocktail of four S.
aureus strains on raw chicken breast pieces at three temperatures (6, 13, and 25°C) to simulate
refrigeration, temperature abuse, and room temperature, respectively. At all three temperatures
(6, 13, and 25°C), there was no significant reduction in the number of bacterial colonies by any
antimicrobial treatment when compared to the positive control at any given time point (Figure 1).
In addition, there was no significant difference between the treatments at any temperature.
Results indicate that at 13 and 25°C 1.5% alpha-pinene and bacteriophage K alone, respectively,
inhibit S. aureus growth slightly better as compared to the other antimicrobial combinations
though this was not significant. At 6 and 13°C, there was no significant effect of EO and
bacteriophage alone or in combination against S. aureus when applied on the raw chicken pieces
(Figure 1).
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Discussion
Foodborne pathogens can exist in raw and processed food, both in meat and vegetable products
(Zaczek et al., 2015). The U.S. Food and Drug Administration stated that bacterial pathogens
such as S. aureus, Shigella sp., and E. coli can be found in vegetables primarily leafy greens,
tomatoes, and other fresh produce that make up salads and raw or ready-to-eat meat products
(Zaczek et al., 2015). The concept of using natural antimicrobials such as bacteriophage and EO
against spoilage bacteria and pathogens in foods has received increasing interest over time, and
many studies support the value of this approach. For instance, Salmonella reduction after
application of bacteriophages has been demonstrated for honeydew melon slices (Leverentz et
al., 2001) and sprouts (Ye et al., 2010). Similarly, EO such as eugenol, coriander, clove,
oregano, and thyme oils have been found to effectively inhibit L. monocytogenes and Aeromonas
hydrophila in refrigerated, cooked poultry products (Skandamis and Nychas, 2001; Hao et al.,
1998).
Based on this, the purpose of this study was to determine the effect of pure EO compounds and a
S. aureus specific bacteriophage, individually and combined, against S. aureus present on the
surface of raw chicken pieces. One previous study has successfully demonstrated the application
of bacteriophage and EO to control E. coli O157:H7 present on baby spinach leaves and lettuces
(Viazis et al., 2011). Other researchers have also reported that bacteriophages were able to
effectively inactivate bacterial pathogens present on fresh produce and fruit such as lettuce
(Sharma et al., 2009; Guenther et al., 2009), honeydew melon (Leverentz et al., 2004), tomatoes
(Ye et al., 2009; Abuladze et al., 2008), spinach, and broccoli (Abuladze et al., 2008). However,
these studies used high MOIs ranging from 1,000 to 100,000 and above. In this study, we applied
bacteriophage at a relatively low MOI (0.1) to the chicken pieces inoculated with S. aureus.
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Studies have shown that the degree of inhibition/killing of bacterial host directly correlates with
the total bacteriophage concentration (Hudson et al., 2013). Although the differences between
the various treatments of bacteriophage and EOs were not statistically significant, there was an
observed reduction of S. aureus counts with the bacteriophage treatment at 25°C which suggests
that it may be possible to further improve the effectiveness of bacteriophage treatment by
increasing the bacteriophage concentration and/or by using larger volumes of antimicrobial
solution per unit of surface area. At 6 and 13 °C incubation, there was no significant decrease in
the growth of S. aureus by any of the treatments. This effect can be explained by the
immobilization of the bacteriophage particles on the chicken surfaces and matrix. Consequently,
there was likely not an optimal distribution of the bacteriophage on the chicken surface in order
to provide the highest probability for contact between bacteriophage and S. aureus. Our findings
suggest that bacteriophage particles became immobilized on the chicken surfaces within the first
few hours after addition, which in turn enabled survival of S. aureus in protected niches. Clearly,
this is dependent on the surface properties and matrix of the raw chicken. Furthermore,
bacteriophages can strongly bind to food molecules with hydrostatic interactions, resulting in
loss of their lytic activity (Ye et al., 2009). A similar phenomenon has been observed
with Listeria bacteriophage applied to contaminated surface-ripened soft cheese (Guenter and
Loessner, 2011). The authors observed that the efficacy of bacteriophage treatment appeared to
be highest at target cell concentrations at or below 100 cfu/cm2. Also, repeated bactriophage
application did not enhance bacterial inhibition when compared to a single dose. There has been
exploration on different bacteriophage delivery systems. Puapermpoonsiri et al. (2009) reported
that bacteriophages specific for S. aureus or Pseudomonas aeruginosa could be encapsulated
into biodegradable polyester microspheres via a modified water/oil/water double emulsion
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solvent extraction protocol resulting in only a partial loss of lytic activity. This type of delivery
method can increase the solubility of bacteriophage in a food matrix such as raw chicken thus
increasing the surface area for bacterial contact and improving the antimicrobial effectiveness
(Shah et al., 2012). Despite the poor shelf-life of the formulation, the work is proof-of-concept
for the formulation and controlled delivery of bacteriophages.
With respect to EOs, the limited water solubility of EOs reduces their effectiveness (Sofos et al.,
1998), and the homogeneity of their distribution in food matrices (such as raw chicken) is
required to ensure the inhibition of microbial growth throughout food products. The
effectiveness of lipophilic EOs in foods may be further reduced because of the interaction with
and/or solubilization by hydrophobic components of foods such as proteins and lipids.
Challenges in dealing with such hydrophobic compounds can be overcome by dissolving them in
a solvent with decreased polarity or dispersing them in emulsion droplets or biopolymer particles
using nanoscale encapsulation systems (Shah et al., 2012). In a study by Gaysinsky et al. (2007),
the antimicrobial activities of EO components such as eugenol and carvacrol against L.
monocytogenes and E. coli O157:H7 were effectively improved by dissolving the EOs in
surfactant micelles smaller than 100 nm.
Conclusions
Staphylococcus aureus are increasingly being reported with high prevalence on raw meat and
ready-to-eat meat products. In the past few years, numerous research groups have evaluated
natural antimicrobials as biocontrol agents for foodborne pathogens. Using S. aureus specific
bacteriophages in combination with pure EO compounds to inhibit the growth of S. aureus on
raw chicken products has the potential to be natural antimicrobials for reducing the incidence of
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foodborne diseases. These natural antimicrobials have a long history and many areas linked with
bacteriophage and EO application still need to be investigated. The data presented in this study
emphasize the need for a more robust delivery technique of these antimicrobials on the meat
surfaces in order to reach maximum inhibition of the target pathogen.
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List of Figures

Figure 1. Effect of bacteriophage K and two essential oils at various time points on the survival
of S. aureus at (A) 6°C, (B) 13°C and (C) 25°C. Line styles used in the graph are indexed as
follows:
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Figure 1. Effect of phage K and two essential oils at various time points on the survival of S.
aureus at (A) 6°C, (B) 13°C and (C) 25°C. Line styles used in the graph are indexed as follows:
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Chapter 4: Overall Conclusions
Staphylococcus aureus is an important human pathogen whose ability to acquire resistance
mechanisms and other pathogenic determinants has added to its emergence in both acute and
community healthcare settings (Adukwu et al., 2012). Staphylococcus aureus are notorious for
their resistance to antibiotics. The occurrence of methicillin resistant S. aureus (MRSA) and the
detection of a vancomycin resistance gene in S. aureus has led to increased concern regarding the
bacteria (Panneerseelan and Muriana, 2009). Since S. aureus is a commensal and lives on the
anatomical locales of humans, food handlers are often a common source of contamination of
foods with S. aureus (Gutierrez et al., 2012). Unfortunately, management of S. aureus infections
in humans has become compromised as a result of multiple antibiotic resistant strains including
MRSA and vancomycin resistant S. aureus (VRSA (Panneerseelan and Muriana, 2009).
Numerous studies have discovered promising novel antimicrobial effects of plant-derived
essential oils (EOs) and bacteriophages (Muthaiyan et al., 2012; Zaczek et al., 2015). Tea tree
oil, ajwaine oil, citrus oil, olive oil, lemongrass, and cinnamon bark have been shown to be lethal
to S. aureus (Chao et al., 2008; Upadhyay et al., 2010; Edwards-Jones et al., 2004). There are a
number of host specific bacteriophages that are used in the food industry. For instance, S.
aureus-specific bacteriophage use during cheese manufacturing (Bueno et al., 2012) and
commercially available bacteriophage cocktails (e.g., Listex™ P100 and ListShield™) are used
for control of L. monocytogenes in raw and RTE foods (Soni et al., 2010). Moreover,
bacteriophages are now accepted as natural food additives since they are naturally present in the
digestive tract of humans and throughout the environment (Monk et al., 2010).
In the research presented here, I hypothesized that combining S. aureus-specific bacteriophage
with EOs can inhibit the growth of S. aureus better than either treatment alone. This is a novel
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approach as this is the first study to report on the use of these two antimicrobials against S.
aureus. Similar research by Viazis et al. (2011) indicated that the combination of E. coli specific
bacteriophage BEC8 and trans-cinnamaldehyde proved highly effective against E.coli O157:H7
on leafy greens. Therefore, based on the reported antimicrobial potential of both EOs and hostspecific bacteriophage, I proposed to investigate the efficacy of varying concentrations of EOs
alone and in combination with S. aureus specific bacteriophage in order to determine potential
synergistic effects. More specifically, I aimed 1) to determine the efficacy of varying
concentrations of pure EOs compounds against S. aureus; 2) to evaluate the efficacy of a S.
aureus-specific bacteriophage against four strains of S. aureus and 3) to combine these
antimicrobials to determine potential synergism and possible application for the control of S.
aureus on raw meat product such as chicken. Chapter 2 focused on the investigation of the
efficacy of pine oil compounds alone in combination with S. aureus bacteriophage K. For the
screening of the pure oil compounds, disc diffusion assay was used and four EOs were chosen
including alpha-pinene, beta-pinene, 3-carene, and limonene as well as five different S. aureus
strains. Based on the DDA, I concluded that alpha-pinene showed significantly higher effect
against all S. aureus strains. Further, growth inhibition assay was performed to analyze which
concentration of EO would have the greatest inhibitory effect. It was concluded that alpha-pinene
and alpha-pinene+3-carene at 1.5% and 3.28% showed subsequently higher inhibitory effect.
In order to evaluate the adsorption properties of bacteriophage K, a phage adsorption assay was
used. I observed that at 37°C, all S. aureus strains were susceptible to bacteriophage K.
Although, at 6 and 13°C, the lytic activity of bacteriophage K gradually decreased over a period
of 6 hours against S. aureus strains. Phage adsorption assay was also performed over a prolonged
period of time (24 to 120 hours) at 6, 13, and 37°C. At 6°C, the number of PFU against all S.
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aureus strains showed fluctuations before decreasing after 120 hours. At 13°C, the number of
PFU remained more or less constant after 72 hours. As expected, at 37°C the number of PFU
was 3 log higher after 24 hours as compared to 6 and 13°C. Last, I tested the effect of both of
these antimicrobials in combination in vitro. Over a period of time all four S. aureus strains
showed a significant reduction in growth, though bacteriophage K with 3.28% α-pinene inhibited
S. aureus growth better than other combinations of EOs and bacteriophage depending on the
strain.
The overall goal of this research was to utilize these antimicrobial compounds for control of S.
aureus as a foodborne pathogen with potential applications in the food industry such as
inactivation of S. aureus of raw chicken products. Hence, these antimicrobials were evaluated
against S. aureus on raw chicken pieces at 6, 13 and 25°C. Interestingly, the inhibitory effect of
these antimicrobials were limited on food matrix. Results indicated that at 25°C bacteriophage K
alone inhibited S. aureus growth better as compared to other antimicrobial combination. At 6 and
13°C, there was no significant effect of EO and bacteriophage alone or in combination against S.
aureus when applied on the raw chicken pieces. This indicates that a better delivery method
needs to be employed in order to get the desired inhibitory effect.
Overall, this research has increased our knowledge related to interactions between antimicrobials
against S. aureus. There is a need for more in depth studies related to the inhibitory effect of
bacteriophage and EO together and alone against bacterial pathogens such as S. aureus.
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